img

Global Biopharmaceutical CMO Services Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biopharmaceutical CMO Services Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Biopharmaceutical CMO Services report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biopharmaceutical CMO Services market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinical Manufacturing and Commercial Manufacturing are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical CMO Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceutical CMO Services key companies include Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie, JRS Pharma, Catalent, Biomeva, Samsung BioLogics and AbbVie, etc. Lonza, Boehringer Ingelheim, AGC Biologics are top 3 players and held % share in total in 2022.
Biopharmaceutical CMO Services can be divided into Biologics Manufacturing, Biosimilars Manufacturing and Others,, etc. Biologics Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical CMO Services is widely used in various fields, such as Clinical Manufacturing, Commercial Manufacturing and Others,, etc. Clinical Manufacturing provides greatest supports to the Biopharmaceutical CMO Services industry development. In 2022, global % share of Biopharmaceutical CMO Services went into Clinical Manufacturing filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CMO Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others

Segment by Application


Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical CMO Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical CMO Services introduction, etc. Biopharmaceutical CMO Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biopharmaceutical CMO Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Biopharmaceutical CMO Services
1.1 Biopharmaceutical CMO Services Market Overview
1.1.1 Biopharmaceutical CMO Services Product Scope
1.1.2 Biopharmaceutical CMO Services Market Status and Outlook
1.2 Global Biopharmaceutical CMO Services Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Biopharmaceutical CMO Services Market Size by Region (2024-2034)
1.4 Global Biopharmaceutical CMO Services Historic Market Size by Region (2024-2024)
1.5 Global Biopharmaceutical CMO Services Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Biopharmaceutical CMO Services Market Size (2024-2034)
1.6.1 North America Biopharmaceutical CMO Services Market Size (2024-2034)
1.6.2 Europe Biopharmaceutical CMO Services Market Size (2024-2034)
1.6.3 Asia-Pacific Biopharmaceutical CMO Services Market Size (2024-2034)
1.6.4 Latin America Biopharmaceutical CMO Services Market Size (2024-2034)
1.6.5 Middle East & Africa Biopharmaceutical CMO Services Market Size (2024-2034)
2 Biopharmaceutical CMO Services Market by Type
2.1 Introduction
2.1.1 Biologics Manufacturing
2.1.2 Biosimilars Manufacturing
2.1.3 Others
2.2 Global Biopharmaceutical CMO Services Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2024-2024)
2.2.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Biopharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Biopharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Biopharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Biopharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
3 Biopharmaceutical CMO Services Market Overview by Application
3.1 Introduction
3.1.1 Clinical Manufacturing
3.1.2 Commercial Manufacturing
3.1.3 Others
3.2 Global Biopharmaceutical CMO Services Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2024-2024)
3.2.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Biopharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Biopharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Biopharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Biopharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
4 Biopharmaceutical CMO Services Competition Analysis by Players
4.1 Global Biopharmaceutical CMO Services Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2022)
4.3 Date of Key Players Enter into Biopharmaceutical CMO Services Market
4.4 Global Top Players Biopharmaceutical CMO Services Headquarters and Area Served
4.5 Key Players Biopharmaceutical CMO Services Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharmaceutical CMO Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Biopharmaceutical CMO Services Products, Services and Solutions
5.1.4 Lonza Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.1.5 Lonza Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Products, Services and Solutions
5.2.4 Boehringer Ingelheim Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 AGC Biologics
5.3.1 AGC Biologics Profile
5.3.2 AGC Biologics Main Business
5.3.3 AGC Biologics Biopharmaceutical CMO Services Products, Services and Solutions
5.3.4 AGC Biologics Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.3.5 Rentschler Biotechnologie Recent Developments
5.4 Rentschler Biotechnologie
5.4.1 Rentschler Biotechnologie Profile
5.4.2 Rentschler Biotechnologie Main Business
5.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Products, Services and Solutions
5.4.4 Rentschler Biotechnologie Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.4.5 Rentschler Biotechnologie Recent Developments
5.5 JRS Pharma
5.5.1 JRS Pharma Profile
5.5.2 JRS Pharma Main Business
5.5.3 JRS Pharma Biopharmaceutical CMO Services Products, Services and Solutions
5.5.4 JRS Pharma Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.5.5 JRS Pharma Recent Developments
5.6 Catalent
5.6.1 Catalent Profile
5.6.2 Catalent Main Business
5.6.3 Catalent Biopharmaceutical CMO Services Products, Services and Solutions
5.6.4 Catalent Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.6.5 Catalent Recent Developments
5.7 Biomeva
5.7.1 Biomeva Profile
5.7.2 Biomeva Main Business
5.7.3 Biomeva Biopharmaceutical CMO Services Products, Services and Solutions
5.7.4 Biomeva Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.7.5 Biomeva Recent Developments
5.8 Samsung BioLogics
5.8.1 Samsung BioLogics Profile
5.8.2 Samsung BioLogics Main Business
5.8.3 Samsung BioLogics Biopharmaceutical CMO Services Products, Services and Solutions
5.8.4 Samsung BioLogics Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.8.5 Samsung BioLogics Recent Developments
5.9 AbbVie
5.9.1 AbbVie Profile
5.9.2 AbbVie Main Business
5.9.3 AbbVie Biopharmaceutical CMO Services Products, Services and Solutions
5.9.4 AbbVie Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.9.5 AbbVie Recent Developments
5.10 Binex
5.10.1 Binex Profile
5.10.2 Binex Main Business
5.10.3 Binex Biopharmaceutical CMO Services Products, Services and Solutions
5.10.4 Binex Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.10.5 Binex Recent Developments
5.11 WuXi Biologics
5.11.1 WuXi Biologics Profile
5.11.2 WuXi Biologics Main Business
5.11.3 WuXi Biologics Biopharmaceutical CMO Services Products, Services and Solutions
5.11.4 WuXi Biologics Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.11.5 WuXi Biologics Recent Developments
5.12 PRA Health Sciences
5.12.1 PRA Health Sciences Profile
5.12.2 PRA Health Sciences Main Business
5.12.3 PRA Health Sciences Biopharmaceutical CMO Services Products, Services and Solutions
5.12.4 PRA Health Sciences Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.12.5 PRA Health Sciences Recent Developments
5.13 ProBioGen
5.13.1 ProBioGen Profile
5.13.2 ProBioGen Main Business
5.13.3 ProBioGen Biopharmaceutical CMO Services Products, Services and Solutions
5.13.4 ProBioGen Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.13.5 ProBioGen Recent Developments
5.14 KBI Biopharma
5.14.1 KBI Biopharma Profile
5.14.2 KBI Biopharma Main Business
5.14.3 KBI Biopharma Biopharmaceutical CMO Services Products, Services and Solutions
5.14.4 KBI Biopharma Biopharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.14.5 KBI Biopharma Recent Developments
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharmaceutical CMO Services Market Dynamics
11.1 Biopharmaceutical CMO Services Industry Trends
11.2 Biopharmaceutical CMO Services Market Drivers
11.3 Biopharmaceutical CMO Services Market Challenges
11.4 Biopharmaceutical CMO Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Biopharmaceutical CMO Services Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Biopharmaceutical CMO Services Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Biopharmaceutical CMO Services Market Size Share by Region (2024-2024)
Table 4. Global Biopharmaceutical CMO Services Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Biopharmaceutical CMO Services Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Biopharmaceutical CMO Services Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Biopharmaceutical CMO Services Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2024)
Table 9. Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Table 11. North America Biopharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Biopharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Biopharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Biopharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Biopharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Biopharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Biopharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Biopharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Biopharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Biopharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Biopharmaceutical CMO Services Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Biopharmaceutical CMO Services Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2024)
Table 24. Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Table 26. North America Biopharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Biopharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Biopharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Biopharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Biopharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Biopharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Biopharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Biopharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Biopharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Biopharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Biopharmaceutical CMO Services Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Biopharmaceutical CMO Services Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2022)
Table 39. Date of Key Players Enter into Biopharmaceutical CMO Services Market
Table 40. Global Biopharmaceutical CMO Services Key Players Headquarters and Area Served
Table 41. Biopharmaceutical CMO Services Product Solution and Service
Table 42. Global Biopharmaceutical CMO Services Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Lonza Basic Information List
Table 45. Lonza Description and Business Overview
Table 46. Lonza Biopharmaceutical CMO Services Products, Services and Solutions
Table 47. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Lonza (2024-2024)
Table 48. Lonza Recent Developments
Table 49. Boehringer Ingelheim Basic Information List
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Biopharmaceutical CMO Services Products, Services and Solutions
Table 52. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Boehringer Ingelheim (2024-2024)
Table 53. Boehringer Ingelheim Recent Developments
Table 54. AGC Biologics Basic Information List
Table 55. AGC Biologics Description and Business Overview
Table 56. AGC Biologics Biopharmaceutical CMO Services Products, Services and Solutions
Table 57. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of AGC Biologics (2024-2024)
Table 58. AGC Biologics Recent Developments
Table 59. Rentschler Biotechnologie Basic Information List
Table 60. Rentschler Biotechnologie Description and Business Overview
Table 61. Rentschler Biotechnologie Biopharmaceutical CMO Services Products, Services and Solutions
Table 62. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Rentschler Biotechnologie (2024-2024)
Table 63. Rentschler Biotechnologie Recent Developments
Table 64. JRS Pharma Basic Information List
Table 65. JRS Pharma Description and Business Overview
Table 66. JRS Pharma Biopharmaceutical CMO Services Products, Services and Solutions
Table 67. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of JRS Pharma (2024-2024)
Table 68. JRS Pharma Recent Developments
Table 69. Catalent Basic Information List
Table 70. Catalent Description and Business Overview
Table 71. Catalent Biopharmaceutical CMO Services Products, Services and Solutions
Table 72. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Catalent (2024-2024)
Table 73. Catalent Recent Developments
Table 74. Biomeva Basic Information List
Table 75. Biomeva Description and Business Overview
Table 76. Biomeva Biopharmaceutical CMO Services Products, Services and Solutions
Table 77. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Biomeva (2024-2024)
Table 78. Biomeva Recent Developments
Table 79. Samsung BioLogics Basic Information List
Table 80. Samsung BioLogics Description and Business Overview
Table 81. Samsung BioLogics Biopharmaceutical CMO Services Products, Services and Solutions
Table 82. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Samsung BioLogics (2024-2024)
Table 83. Samsung BioLogics Recent Developments
Table 84. AbbVie Basic Information List
Table 85. AbbVie Description and Business Overview
Table 86. AbbVie Biopharmaceutical CMO Services Products, Services and Solutions
Table 87. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of AbbVie (2024-2024)
Table 88. AbbVie Recent Developments
Table 89. Binex Basic Information List
Table 90. Binex Description and Business Overview
Table 91. Binex Biopharmaceutical CMO Services Products, Services and Solutions
Table 92. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of Binex (2024-2024)
Table 93. Binex Recent Developments
Table 94. WuXi Biologics Basic Information List
Table 95. WuXi Biologics Description and Business Overview
Table 96. WuXi Biologics Biopharmaceutical CMO Services Products, Services and Solutions
Table 97. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of WuXi Biologics (2024-2024)
Table 98. WuXi Biologics Recent Developments
Table 99. PRA Health Sciences Basic Information List
Table 100. PRA Health Sciences Description and Business Overview
Table 101. PRA Health Sciences Biopharmaceutical CMO Services Products, Services and Solutions
Table 102. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of PRA Health Sciences (2024-2024)
Table 103. PRA Health Sciences Recent Developments
Table 104. ProBioGen Basic Information List
Table 105. ProBioGen Description and Business Overview
Table 106. ProBioGen Biopharmaceutical CMO Services Products, Services and Solutions
Table 107. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of ProBioGen (2024-2024)
Table 108. ProBioGen Recent Developments
Table 109. KBI Biopharma Basic Information List
Table 110. KBI Biopharma Description and Business Overview
Table 111. KBI Biopharma Biopharmaceutical CMO Services Products, Services and Solutions
Table 112. Revenue (US$ Million) in Biopharmaceutical CMO Services Business of KBI Biopharma (2024-2024)
Table 113. KBI Biopharma Recent Developments
Table 114. North America Biopharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 115. North America Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 116. Europe Biopharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 117. Europe Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 118. Asia-Pacific Biopharmaceutical CMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2024-2024) & (US$ Million)
Table 120. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2024-2034) & (US$ Million)
Table 121. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2024-2024)
Table 122. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2024-2034)
Table 123. Latin America Biopharmaceutical CMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 124. Latin America Biopharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 125. Latin America Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 126. Middle East & Africa Biopharmaceutical CMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 127. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 128. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 129. Biopharmaceutical CMO Services Market Trends
Table 130. Biopharmaceutical CMO Services Market Drivers
Table 131. Biopharmaceutical CMO Services Market Challenges
Table 132. Biopharmaceutical CMO Services Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO Services Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Biopharmaceutical CMO Services Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Biopharmaceutical CMO Services Market Share by Regions: 2022 VS 2034
Figure 4. Global Biopharmaceutical CMO Services Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Biopharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Biopharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Biopharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Biopharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Biopharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Biologics Manufacturing
Figure 11. Global Biologics Manufacturing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Biosimilars Manufacturing
Figure 13. Global Biosimilars Manufacturing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Biopharmaceutical CMO Services Market Size Share by Type: 2022 & 2034
Figure 17. North America Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 18. Europe Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Biopharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 22. Clinical Manufacturing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Commercial Manufacturing Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Biopharmaceutical CMO Services Market Size Share by Application: 2022 & 2034
Figure 26. North America Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 27. Europe Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Biopharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 31. Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Biopharmaceutical CMO Services Market Share in 2022
Figure 33. North America Biopharmaceutical CMO Services Market Share by Country (2024-2034)
Figure 34. United States Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 37. France Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2024-2034)
Figure 43. China Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 47. India Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Biopharmaceutical CMO Services Market Share by Country (2024-2034)
Figure 50. Mexico Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Biopharmaceutical CMO Services Market Share by Country (2024-2034)
Figure 53. Turkey Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Biopharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report